Cell Source, Inc. vs Zivo Bioscience Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Cell Source, Inc. and Zivo Bioscience Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Jul 30, 2023 for Zivo Bioscience Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet. Zivo Bioscience Inc.'s value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
- Both made a net loss: $5 M for Cell Source, Inc. and $13 M for Zivo Bioscience Inc.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cell Source, Inc. CLCS | Zivo Bioscience Inc. ZIVO |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Revenue | — | $0 M |
| Net income | $-5 M▲ best | $-13 M |
| Altman Z-score zone | — | — |
| Data as of | Market cap Dec 2022; ratios FY2024 | Market cap Jul 2023; ratios FY2024 |
Questions and answers#
Which is bigger, Cell Source, Inc. or Zivo Bioscience Inc.?
Cell Source, Inc. and Zivo Bioscience Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Jul 30, 2023 for Zivo Bioscience Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet. Zivo Bioscience Inc.'s value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Which makes more money, Cell Source, Inc. or Zivo Bioscience Inc.?
Both made a net loss: $5 M for Cell Source, Inc. and $13 M for Zivo Bioscience Inc.